Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 μg) in women with postmenopausal symptoms: Updated analysis of three randomized, controlled trials
- 1 June 2006
- journal article
- research article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 28 (6), 921-932
- https://doi.org/10.1016/j.clinthera.2006.06.013
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Recommendations for estrogen and progestogen use in peri-and postmenopausal women: October 2004 position statement of The North American Menopause SocietyMenopause, 2004
- Low-Dose Estrogen Therapy for Menopausal Women: A Review of Efficacy and SafetyJournal of Women's Health, 2003
- Low-Dose Hormone Therapy for Postmenopausal WomenClinical Obstetrics and Gynecology, 2003
- Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in womenMenopause, 2003
- Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause SocietyMenopause, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Effect of Lower Doses of Conjugated Equine Estrogens With and Without Medroxyprogesterone Acetate on Bone in Early Postmenopausal WomenJAMA, 2002
- The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt??) on the frequency and intensity of vasomotor symptomsMenopause, 2000
- Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinationsPublished by Ovid Technologies (Wolters Kluwer Health) ,2000
- The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trialPublished by American Medical Association (AMA) ,1996